Patents by Inventor Dennis Michael Lambert

Dennis Michael Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
    Patent number: 6017536
    Abstract: The present invention relates to peptides which exhibit antifusogenic and antiviral activities. The peptides of the invention consist of a 16 to 39 amino acid region of a simian immunodeficiency virus (SIV) protein. These regions were identified through computer algorithms capable of recognizing the ALLMOTI5, 107.times.178.times.4, or PLZIP amino acid motifs. These motifs are associated with the antifusogenic and antiviral activities of the claimed peptides.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: January 25, 2000
    Assignee: Trimeris, Inc.
    Inventors: Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois
  • Measles virus peptides with antifusogenic and antiviral activities
    Patent number: 6013263
    Abstract: The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 11, 2000
    Assignee: Trimeris, Inc.
    Inventors: Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway